Fees

The Human Research Protection Office (HRPO) charges for Institutional Review Board (IRB) review of research studies that are supported by industry or other for-profit companies; this includes PI initiated studies supported by industry. There will be no fees assessed for review of research studies funded by federal or state agencies, not for profit foundations, or for internally funded research.  Payment of IRB reviewing fees will be required for all research studies that receive financial support from a for-profit sponsor, regardless of the designation of the support, for example:  If you are only receiving drug or device, IRB fees will not be charged, however, if you are receiving any type of funding, for clerical or administrative support, IRB reviewing fees will be charged.

IRB fees are non-refundable.   The fees are an assessment for the administrative costs associated with IRB review.  Because HPRO commits its full resources to each review, the fees are due in full, even if the study is not approved, participants are never enrolled, a research contract is never executed, or the study is terminated before the study objectives are achieved.  HRPO requires payment of the fees prior to releasing the study for accrual.  

When HRPO receives the study submission, an invoice will be processed using the department number designated on the submission form.  In some limited extenuating circumstances, the IRB Executive Chair may agree to modify the assessment of IRB fees, all requests must be submitted in writing by the investigator and include a rationale for requesting the fee modification. 

It is the principal investigator’s responsibility to incorporate the appropriate IRB fees in the study budget and the contract and include the all applicable institutional and department overhead charges.

No fees will be charged for other categories of research.

Last updated: 5/1/08